Louisiana 2023 Regular Session

Louisiana House Bill HR201

Introduced
5/24/23  
Introduced
5/24/23  
Refer
5/25/23  
Report Pass
5/31/23  
Report Pass
5/31/23  

Caption

Creates a subcommittee to study the effectiveness of sickle cell healthcare treatment practices in this state

Impact

The resolution emphasizes the ongoing challenges that patients with sickle cell disease encounter, including higher rates of hospitalization and shorter life expectancy. It seeks to ensure that the measures enacted by the Louisiana Legislature, such as the establishment of a statewide Sickle Cell Disease Registry, are effective in improving patients' health outcomes. By forming this subcommittee, HR201 intends to assess the current healthcare practices and identify areas for improvement, which could ultimately influence state healthcare policy.

Summary

House Resolution 201 (HR201) aims to create a subcommittee to study the effectiveness of sickle cell healthcare treatment practices in Louisiana. The resolution underscores significant health disparities faced by individuals with sickle cell disease, noting that these patients often experience worse health outcomes compared to those without the condition. The bill highlights the need for improved healthcare monitoring systems and treatment practices for sickle cell patients, which is vital for enhancing their overall health and life expectancy.

Sentiment

The sentiment surrounding HR201 is largely positive, as the resolution is recognized as a step towards addressing health inequities for sickle cell patients in Louisiana. There is a consensus among legislators that such studies are essential for improving the lives of those affected by this genetic blood disorder. The resolution reflects a commitment to enhancing patient care and ensures that the issue of sickle cell disease remains at the forefront of healthcare discussions in the state.

Contention

While HR201 aims for constructive evaluation of sickle cell treatment practices, there may be some contention concerning resource allocation for the subcommittee's activities and the potential findings. The effectiveness of existing treatment protocols and healthcare systems in supporting sickle cell patients is crucial, and any recommendations may necessitate significant changes in practice or policy that could prompt debate among stakeholders, including healthcare providers and patients.

Companion Bills

No companion bills found.

Previously Filed As

LA HR302

Ensuring greater access to sickle cell disease treatments and designating the Department of Health to conduct a comprehensive and coordinated data collection effort to better understand and quantify the scope and impact of sickle cell disease on patients, communities and states throughout the United States.

LA H0353

Sickle Cell Disease Treatment of Pain Continuing Education

LA HB760

Provides relative to unauthorized fees charged by healthcare providers for certain treatments

LA SR292

A resolution expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

LA SR416

A resolution expressing support for the designation of September 2025 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

LA HR524

Expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

LA H0333

Sickle Cell Care Management and Treatment Education

LA HB333

Sickle Cell Care Management and Treatment Education:

LA S0844

Sickle Cell Disease Care Management and Treatment Continuing Education

LA HB1796

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Similar Bills

LA HB246

Provides relative to the Children's Cabinet Advisory Board

LA SR69

Commends and recognizes Film Louisiana for its contributions to economic development and designates April 15, 2026, as Film Louisiana Day at the Louisiana State Capitol

LA SR10

Requests the health profession licensing boards to work with the commissioner of administration to identify funds from their cash and cash equivalent year-end balances that can be transferred into the state general fund.

LA SR34

Commends Geaux Far Louisiana and designates Tuesday, March 24, 2026, as Geaux Far Louisiana Day at the Louisiana State Capitol.

LA HCR66

Requests Louisiana Economic Development to develop and implement a coordinated rural economic development strategy

LA HCR76

Continues the Health Inequities and Disparities in Rural Areas Task Force

LA SCR7

Establishes the Police Training, Screening, and De-escalation Task Force to study and make recommendations to the legislature.

LA HR344

Creates a task force to study substance use trends and treatment among wards of the state